Lee Financial’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-5
Closed -$2.78K – 475
2023
Q4
$2.78K Hold
5
– – ﹤0.01% 682
2023
Q3
$2.19K Hold
5
– – ﹤0.01% 661
2023
Q2
$2.51K Hold
5
– – ﹤0.01% 618
2023
Q1
$2.5K Sell
5
-1
-17% -$479 ﹤0.01% 632
2022
Q4
$2.45K Buy
6
+5
+500% +$1.94K ﹤0.01% 654
2022
Q3
$0 Hold
1
– – ﹤0.01% 904
2022
Q2
$0 Buy
+1
New +$408 ﹤0.01% 911
2022
Q1
– Sell
-4
Closed -$3K – 853
2021
Q4
$3K Buy
+4
New +$2.51K ﹤0.01% 672
2018
Q2
– Sell
-45
Closed -$9K – 805
2018
Q1
$9K Hold
45
– – ﹤0.01% 495
2017
Q4
$7K Hold
45
– – ﹤0.01% 398
2017
Q3
$7K Hold
45
– – ﹤0.01% 387
2017
Q2
$7K Sell
45
-15
-25% -$2.44K ﹤0.01% 375
2017
Q1
$9K Hold
60
– – ﹤0.01% 290
2016
Q4
$7K Buy
+60
New +$6.85K ﹤0.01% 343

Other funds holding IDXX

Lee Financial's IDXX Position: Q1 2024 in Review

Lee Financial sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 5 shares — an estimated $2.78K sold.

Lee Financial first reported a position in IDXX in Q4 2016 and held it in 14 quarters. The position peaked at $9K in Q1 2018. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Lee Financial reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 5 Idexx Laboratories shares in Q1 2024, an estimated $2.78K.
  • Lee Financial first reported a position in Idexx Laboratories in Q4 2016 and held it in 14 quarters.
  • Lee Financial's Idexx Laboratories position peaked at $9K in Q1 2018.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.